EPFL scientists have developed a unique system that can be used for detecting and analyzing molecules with very a level of high precision and without using any bulky equipment. This latest development paves the way for large-scale, image-based detection of materials assisted by artificial intelligence. The study has been reported in Science.
Organic compounds are typically detected and analyzed by infrared spectroscopy, but this method calls for complex procedures as well as huge and costly instruments which make device miniaturization quite difficult and thus limits its applications in certain medical and industrial applications and for collecting data out in the field, for example, for determining the concentrations of pollutants. Infrared spectroscopy is also essentially restricted by low sensitivities and thus needs large amounts of samples.
Conversely, a research team from EPFL’s School of Engineering and Australian National University (ANU) has designed a sensitive and compact nanophotonic system that is capable of identifying the absorption characteristics of a molecule without using traditional spectrometry. The researchers have already detected organic compounds, polymers, and pesticides with their system, which can also be used with CMOS technology.
The novel system features an engineered surface which is surrounded with countless numbers of very small sensors known as metapixels. These metapixels can create a unique bar code for each molecule that the surface comes into contact, and using advanced pattern recognition and sorting technology (for example, artificial neural networks) these bar code can be extensively analyzed. This study – which turns out to be a meeting point of nanotechnology, physics, and big data – has been reported in the Science journal.
Image Credit: © 2018 EPFL
News This Week
Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble [...]
A technology developed at Vanderbilt University Medical Center has led to the discovery of an "ultra-potent" monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. The antibody [...]
Research has found a significant fall in levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, 6 months after the second dose of the Pfizer-BioNTech vaccine. Clinical evidence also suggests that the risk [...]
Are the COVID vaccines substantially different from/inferior to other vaccines in terms of their effectiveness? The issue raised, and I'm mostly paraphrasing here, is this: Most vaccines (e.g. measles, smallpox) have efficacy defined such [...]
The EVONANO platform allows scientists to grow virtual tumors and use artificial intelligence to automatically optimize the design of nanoparticles to treat them. The ability to grow and treat virtual tumors is an [...]
Modern Approaches to Augmentation of Brain Function Available from Springer Press This book covers recent advances in neural technology that provide for enhancements for brain function. It addresses a broad range of neural phenomena [...]
Although the currently available COVID-19 vaccines are highly effective, limited manufacturing capacity and the need for cold-chain storage hinder their global distribution. A recent study tested the efficacy of a new adeno-associated virus (AAV) [...]